Radiation therapy firm Accuray announced that it has completed the purchase of TomoTherapy.
With the closing of the transaction, Accuray's installed base increases from 226 to more than 550 systems, the company said, and its total number of employees doubles to more than 1,000 worldwide.
Corporate headquarters will remain in Sunnyvale, CA, but the company will maintain a presence in Madison, WI, where TomoTherapy's headquarters have been located. Euan Thomson, PhD, will continue to serve as president and chief executive officer of Accuray, according to the firm.
With the closing of the transaction, TomoTherapy common stock will no longer be listed on Nasdaq.
